{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:24:30Z","timestamp":1786937070558,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Advanced Program of the Affiliated Hospital of Xuzhou Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,9,5]]},"DOI":"10.1038\/s41416-026-03477-z","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T18:03:31Z","timestamp":1779991411000},"page":"791-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactylation-related prognostic signature characterized in pancreatic ductal adenocarcinoma through public scRNA-seq dataset and machine learning algorithms: the TOP2A-H3K18la-NQO1 axis orchestrates malignant progression"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6865-3928","authenticated-orcid":false,"given":"Haodong","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonglei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aozhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-5591","authenticated-orcid":false,"given":"Hongqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6827-0627","authenticated-orcid":false,"given":"Wenxing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"3477_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3477_CR2","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.pan.2022.04.011","volume":"22","author":"J Chen","year":"2022","unstructured":"Chen J, Chen H, Zhang T, Yin X, Man J, Yang X, et al. Burden of pancreatic cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030. Pancreatology. 2022;22:608\u201318.","journal-title":"Pancreatology"},{"key":"3477_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/cco-21-87","volume":"11","author":"T Okusaka","year":"2022","unstructured":"Okusaka T. Treatment for postoperative recurrence of pancreatic cancer: a narrative review. Chin Clin Oncol. 2022;11:19.","journal-title":"Chin Clin Oncol"},{"key":"3477_CR4","first-page":"56","volume":"60","author":"E Racker","year":"1972","unstructured":"Racker E. Bioenergetics and the problem of tumor growth. Am Sci. 1972;60:56\u201363.","journal-title":"Am Sci"},{"key":"3477_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3119375","volume":"2022","author":"Y Gao","year":"2022","unstructured":"Gao Y, Zhou H, Liu G, Wu J, Yuan Y, Shang A. Tumor microenvironment: lactic acid promotes tumor development. J Immunol Res. 2022;2022:3119375.","journal-title":"J Immunol Res"},{"key":"3477_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305662","volume":"11","author":"Q Cheng","year":"2024","unstructured":"Cheng Q, Shi XL, Li QL, Wang L, Wang Z. Current advances on nanomaterials interfering with lactate metabolism for tumor therapy. Adv Sci (Weinh). 2024;11:e2305662.","journal-title":"Adv Sci (Weinh)"},{"key":"3477_CR7","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1172\/JCI69741","volume":"123","author":"JR Doherty","year":"2013","unstructured":"Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123:3685\u201392.","journal-title":"J Clin Invest"},{"key":"3477_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351.","journal-title":"Nature"},{"key":"3477_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3477_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101758","volume":"37","author":"MR Pandkar","year":"2023","unstructured":"Pandkar MR, Sinha S, Samaiya A, Shukla S. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression. Transl Oncol. 2023;37:101758.","journal-title":"Transl Oncol"},{"key":"3477_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111913","volume":"132","author":"PR Gan","year":"2024","unstructured":"Gan PR, Wu H, Zhu YL, Shu Y, Wei Y. Glycolysis, a driving force of rheumatoid arthritis. Int Immunopharmacol. 2024;132:111913.","journal-title":"Int Immunopharmacol"},{"key":"3477_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330.","journal-title":"Autophagy"},{"key":"3477_CR13","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.ijbiomac.2022.10.014","volume":"222","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang Z, Yu Y, Zhang P. HIF1\u03b1 lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 2022;222:2225\u201343.","journal-title":"Int J Biol Macromol"},{"key":"3477_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106460","volume":"152","author":"J Zhang","year":"2023","unstructured":"Zhang J, Liu X, Huang Z, Wu C, Zhang F, Han A, et al. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing. Comput Biol Med. 2023;152:106460.","journal-title":"Comput Biol Med"},{"key":"3477_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41368-024-00292-1","volume":"16","author":"K Li","year":"2024","unstructured":"Li K, Zhang C, Zhou R, Cheng M, Ling R, Xiong G, et al. Single cell analysis unveils B cell-dominated immune subtypes in HNSCC for enhanced prognostic and therapeutic stratification. Int J Oral Sci. 2024;16:29.","journal-title":"Int J Oral Sci"},{"key":"3477_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04955-9","volume":"22","author":"H Huang","year":"2024","unstructured":"Huang H, Chen K, Zhu Y, Hu Z, Wang Y, Chen J, et al. A multi-dimensional approach to unravel the intricacies of lactylation related signature for prognostic and therapeutic insight in colorectal cancer. J Transl Med. 2024;22:211.","journal-title":"J Transl Med"},{"key":"3477_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.804190","volume":"13","author":"LY Xie","year":"2022","unstructured":"Xie LY, Huang HY, Fang T, Liang JY, Hao YL, Zhang XJ, et al. A prognostic survival model of pancreatic adenocarcinoma based on metabolism-related gene expression. Front Genet. 2022;13:804190.","journal-title":"Front Genet"},{"key":"3477_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241239042","volume":"18","author":"S Tan","year":"2024","unstructured":"Tan S, Tang H, Zhang Z, Wang Y, Li H, Shi W, et al. Identification of transcriptomic signatures of pancreatic ductal adenocarcinoma-derived exosomes that promote macrophage M2 polarization and predict prognosis: S100A9 reveals tumor progression. Clin Med Insights Oncol. 2024;18:11795549241239042.","journal-title":"Clin Med Insights Oncol"},{"key":"3477_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101877","volume":"41","author":"S Ruan","year":"2024","unstructured":"Ruan S, Wang H, Zhang Z, Yan Q, Chen Y, Cui J, et al. Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma. Transl Oncol. 2024;41:101877.","journal-title":"Transl Oncol"},{"key":"3477_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1184708","volume":"10","author":"D Yang","year":"2023","unstructured":"Yang D, Zhao F, Su Y, Zhou Y, Shen J, Zhao K, et al. Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy. Front Mol Biosci. 2023;10:1184708.","journal-title":"Front Mol Biosci"},{"key":"3477_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12876-023-02748-w","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lin X, Zou X, Qian Y, Liu Y, Wang R, et al. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. BMC Gastroenterol. 2023;23:113.","journal-title":"BMC Gastroenterol"},{"key":"3477_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03632-z","volume":"20","author":"C Yan","year":"2022","unstructured":"Yan C, Niu Y, Li F, Zhao W, Ma L. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. J Transl Med. 2022;20:455.","journal-title":"J Transl Med"},{"key":"3477_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945878","volume":"13","author":"Y Su","year":"2022","unstructured":"Su Y, Qi R, Li L, Wang X, Li S, Zhao X, et al. An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Front Immunol. 2022;13:945878.","journal-title":"Front Immunol"},{"key":"3477_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cca.2021.03.020","volume":"518","author":"A Li","year":"2021","unstructured":"Li A, Hou S, Chen J, Jiang Y. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Clin Chim Acta. 2021;518:156\u201361.","journal-title":"Clin Chim Acta"},{"key":"3477_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1022420","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Zhang X, Zhang Q, Zhang T, Xie J, Wei W, et al. A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis. Front Immunol. 2022;13:1022420.","journal-title":"Front Immunol"},{"key":"3477_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90.","journal-title":"Mol Cancer"},{"key":"3477_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep07769","volume":"5","author":"H Lee","year":"2015","unstructured":"Lee H, Oh ET, Choi BH, Park MT, Lee JK, Lee JS, et al. NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation. Sci Rep. 2015;5:7769.","journal-title":"Sci Rep"},{"key":"3477_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tibs.2016.02.003","volume":"41","author":"R Haas","year":"2016","unstructured":"Haas R, Cucchi D, Smith J, Pucino V, Macdougall CE, Mauro C. Intermediates of metabolism: from bystanders to signalling molecules. Trends Biochem Sci. 2016;41:460\u201371.","journal-title":"Trends Biochem Sci"},{"key":"3477_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, Yan C, Ma J, Peng P, Ren X, Cai S, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5:61\u201379.","journal-title":"Nat Metab"},{"key":"3477_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:85.","journal-title":"Genome Biol"},{"key":"3477_CR31","first-page":"4343","volume":"12","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhu Q, Li X, Ren X, Li J, Zhang Y, et al. TOP2A inhibition reverses drug resistance of hepatocellular carcinoma to regorafenib. Am J Cancer Res. 2022;12:4343\u201360.","journal-title":"Am J Cancer Res"},{"key":"3477_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-87286-z","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Zheng L, Zhang Y, Tian J. Mechanistic insights into pachymic acid\u2019s action on triple-negative breast Cancer through TOP2A targeting. Sci Rep. 2025;15:2856.","journal-title":"Sci Rep"},{"key":"3477_CR33","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.7150\/jca.41415","volume":"11","author":"F Kou","year":"2020","unstructured":"Kou F, Sun H, Wu L, Li B, Zhang B, Wang X, et al. TOP2A promotes lung adenocarcinoma cells\u2019 malignant progression and predicts poor prognosis in lung adenocarcinoma. J Cancer. 2020;11:2496\u2013508.","journal-title":"J Cancer"},{"key":"3477_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/ijbs.55636","volume":"17","author":"SL Liu","year":"2021","unstructured":"Liu SL, Cai C, Yang ZY, Wu ZY, Wu XS, Wang XF, et al. DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163\/TOP2A and activating Wnt\/\u03b2-catenin pathway. Int J Biol Sci. 2021;17:498\u2013513.","journal-title":"Int J Biol Sci"},{"key":"3477_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.canlet.2019.03.054","volume":"453","author":"Y Yang","year":"2019","unstructured":"Yang Y, Zhu G, Dong B, Piao J, Chen L, Lin Z. The NQO1\/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming. Cancer Lett. 2019;453:170\u201383.","journal-title":"Cancer Lett"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03477-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:44:29Z","timestamp":1786934669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,5]]}},"alternative-id":["3477"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03477-z","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All patients involved in this study provided informed consent. The research was approved by the Ethics Committee of Zhongda Hospital, Southeast University (Approval Number: 2024ZDSYLL378-P01) and was conducted in accordance with the ethical standards stipulated in the 1964 Declaration of Helsinki. Animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of Southeast University, which also approved all animal procedures (Approval Number: 20230306002).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}